STAGE IV NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE IV NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE IV NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for Tough-to-Treat cancers
Disease control OngoingThis early-phase study tested a new drug called sEphB4-HSA combined with standard chemotherapy in 61 people with advanced or metastatic solid tumors (like head and neck, pancreatic, lung, and gallbladder cancers). The goal was to find the best dose and check for side effects. Res…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 01, 2026 18:27 UTC
-
Double-Drug attack on lung cancer: could two be better than one?
Disease control OngoingThis study looked at whether adding a second drug (cetuximab) to the standard pill afatinib helps people with advanced EGFR-mutant lung cancer live longer. About 174 newly diagnosed patients took part. The goal was to see if the combo improved 2-year survival and delayed cancer g…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE2, PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC